The advancement and practice of allergy and immunology through meetings, education, and by promoting and stimulating research and study for optimal patient care.
In care of Executive Director INC
Donations are tax-deductible
Category
Other
Employees
0
Volunteers
91
Financial Snapshot
FY ending 2024-12-31
Revenue
$17.6M
Expenses
$15.7M
Assets
$41.5M
Liabilities
$6.9M
Financial history
$17.6M$8.8M$0
161718192021222324
RevenueExpenses
Latest FY2024: $17.6M · Avg: $14.7M
Foreign activity (Schedule F)
Total spent abroad$39K
Foreign employees8
Foreign offices0
Foreign partnership interestNo
Foreign trust interestNo
Region
Activity
Spent
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,
—
—
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM
—
—
501(h) election
This 501(c)(3) has NOT elected 501(h) — lobbying is permitted but limited under the vaguer "no substantial part of activities" test.